---
figid: PMC5611863__nihms897656f2
figlink: /pmc/articles/PMC5611863/figure/F2/
number: Figure 2
caption: Several small-molecule inhibitors targeting different nodes in this pathway
  are under development for the treatment of cancer. Currently, idelalisib, which
  selectively targets the PI3Kδ isoform, is the only PI3K inhibitor to be approved
  by regulatory agencies is idelalisib.
pmcid: PMC5611863
papertitle: The landscape of new drugs in lymphoma.
reftext: Anas Younes, et al. Nat Rev Clin Oncol. ;14(6):335-346.
pmc_ranked_result_index: '3318'
pathway_score: 0.9278883
filename: nihms897656f2.jpg
figtitle: Landscape of new drugs in lymphoma
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5611863__nihms897656f2.html
  '@type': Dataset
  description: Several small-molecule inhibitors targeting different nodes in this
    pathway are under development for the treatment of cancer. Currently, idelalisib,
    which selectively targets the PI3Kδ isoform, is the only PI3K inhibitor to be
    approved by regulatory agencies is idelalisib.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT3
  - AKT1
  - BAD
  - EIF4EBP1
  - TP53
  - FOXO4
  - RPS6KB1
  - RPTOR
  - MTOR
  - FOXO1
  - GSK3A
  - FOXO6
  - GSK3B
  - FOXO3
  - Temsirolimus
  - Ridaforolimus
  - Cancer
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: 4EBP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Ridaforolimus
  source: MESH
  identifier: C515074
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
